The role of 5-Hydroxymethylcytosine in Aging and Alzheimer's disease: Current status and prospects for future studies

Current Alzheimer Research

Volumn 9, Issue 5, 2012, Pages 545-549

  van den Hove, Daniel L A ^a,b,c   Chouliaras, Leonidas ^a   Rutten, Bart P F ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c NONE   (Netherlands)

Author keywords

5 hydroxymethylcytosine; Aging; Alzheimer's disease; DNA; Epigenesis; Epigenetics; Hydroxymethylation

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; DNA; ENZYME; TEN ELEVEN TRANSLOCATION ENZYME; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ARTICLE; DEMETHYLATION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 84861118285     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512800618008     Document Type: Article

References (48)

1. Penn NW, Suwalski R, O'Riley C, Bojanowski K, Yura R. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem J 1264: 781-90 (1972).
2. Kothari RM, Shankar V. 5-Methylcytosine content in the vertebrate deoxyribonucleic acids: species specificity. J Mol Evol 74: 325-9 (1976).
3. Gommers-Ampt JH, Borst P. Hypermodified bases in DNA. FASEB J 911: 1034-42 (1995).
4. Kriaucionis S, Heintz N. The nuclear DNA base 5- hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 3245929: 929-30 (2009).
5. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell selfrenewal and inner cell mass specification. Nature 4667310: 1129-33 (2010).
6. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 3245929: 930-5 (2009).
7. Williams K, Christensen J, Pedersen MT, Christensen J, Pedersen MT, Johansen JV, et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473(7347): 343-8 (2011).
8. Munzel M, Globisch D, Bruckl T, Wagner M, Welzmiller V, Michalakis S, et al. Quantification of the sixth DNA base hydroxymethylcytosine in the brain. Angew Chem Int Ed Engl 4931: 5375-7 (2010).
9. Globisch D, Munzel M, Muller M, Michalakis S, Wagner M, Koch S, et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 512: e15367 (2010).
10. Dahl C, Gronbaek K, Guldberg P. Advances in DNA methylation: 5-hydroxymethylcytosine revisited. Clin Chim Acta 41211-12: 831-6 (2011).
11. Jin SG, Wu X, Li AX, Pfeifer G.P. Genomic mapping of 5- hydroxymethylcytosine in the human brain. Nucleic Acids Res 39(12), 5015-24 (2011).
12. Song CX, Szulwach KE, Fu Y, Dai Q, Yi C, Li X, et al. Selective chemical labeling reveals the genome-wide distribution of 5- hydroxymethylcytosine. Nat Biotechnol 291: 68-72 (2011).
13. Jin SG, Kadam S, Pfeifer GP. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res 3811: e125 (2010).
14. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 3214: 4100-8 (2004).
15. Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, Hore TA, et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473(7347): 398-402 (2011).
16. Munzel M, Globisch D, Carell T. 5-Hydroxymethylcytosine, the Sixth Base of the Genome. Angew Chem Int Ed Engl 50(29): 6460-8. doi: 10.1002/anie.201101547 (2011).
17. Guo JU, Su Y, Zhong C, Ming GL, Song H. Hydroxylation of 5- Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain Cell 145(3): 423-34 (2011).
18. Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 673: 946-50 (2007).
19. Kinney SM, Chin HG, Vaisvila R, Bitinaite J, Zheng Y, Estève PO, et al. Tissue specific distribution and dynamic changes of 5- hydroxymethylcytosine in mammalian genome. J Biol Chem 286(28): 24685-93 (2011).
20. Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res 6214: 4075-80 (2002).
21. Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing J.R. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11) (q22;q23). Leukemia 173: 637-41 (2003).
22. Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 4687325: 839-43 (2011).
23. Pastor WA, Pape UJ, Huang Y, Henderson HR, Lister R, Ko M, et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 4737347: 394-7 (2011).
24. Koh KP, Yabuuchi A, Rao S, Huang Y, Cunniff K, Nardone J, et al. Tet1 and tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 82: 200-13 (2011).
25. Wu H, D'Alessio AC, Ito S, Wang Z, Cui K, Zhao K, et al. Genome- wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev 257: 679-84 (2011).
26. Ruzov A, Tsenkina Y, Serio A, Dudnakova T, Fletcher J, Bai Y, et al. Lineage-specific distribution of high levels of genomic 5- hydroxymethylcytosine in mammalian development. Cell Res 219: 1332-42 (2011).
27. Szulwach KE, Li X, Li Y, Song CX, Han JW, Kim S, et al. Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet 76: e1002154 (2011).
28. Guo JU, Su Y, Zhong C, Ming GL, Song H. Hydroxylation of 5- Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain. Cell 1453: 423-34
29. Ma DK, Jang MH, Guo JU, Kitabatake Y, Chang ML, Pow-Anpongkul N, et al. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 3235917: 1074-7 (2009).
30. Chouliaras L, van den Hove DL, Kenis G, Keitel S, Hof PR, van Os J, et al. Age-related increase in levels of 5- hydroxymethylcytosine in mouse hippocampus is prevented by caloric restriction. Curr Alzheimer Res 9(5): 536-544 (2012).
31. Morgan, A.R., G. Hamilton, D. Turic, Jehu L, Harold D, Abraham R, et al. Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 147B6: 727-31 (2008).
32. Chouliaras L, Rutten BP, Kenis G, Peerbooms O, Visser PJ, Verhey F, et al. Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog Neurobiol 904: 498-510 (2010).
33. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J, et al. Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging 32(7); 1161-80 (2011).
34. Huang Y, Pastor WA, Shen Y, et al. The behaviour of 5- hydroxymethylcytosine in bisulfite sequencing. PLoS One 51: e8888 (2010).
35. Nestor C, Ruzov A, Meehan R, Dunican D. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5- methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 484: 317-9 (2010).
36. Jin M, Kawakami K, Fukui Y, Tsukioka S, Oda M, Watanabe G, et al. Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels. Cancer Sci 10012: 2325-30 (2009).
37. Song CX, He C. Bioorthogonal Labeling of 5-Hydroxymethylcytosine in Genomic DNA and Diazirine-Based DNA Photo-Cross-Linking Probes. Acc Chem Res (2011).
38. Robertson AB, Dahl JA, Vagbo CB, Tripathi P, Krokan HE, Klungland A, et al. A novel method for the efficient and selective identification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res 398: e55 (2011).
39. Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res 3819: e181 (2011).
40. Davis T, Vaisvila R. High sensitivity 5-hydroxymethylcytosine detection in Balb/C brain tissue. J Vis Exp 48 (2011).
41. Le T, Kim KP, Fan G, Faull KF. A sensitive mass spectrometry method for simultaneous quantification of DNA methylation and hydroxymethylation levels in biological samples. Anal Biochem 4122: 203-9 (2011).
42. Flusberg BA, Webster DR, Lee JH, Travers KJ, Olivares EC, Clark TA, et al. Direct detection of DNA methylation during singlemolecule, real-time sequencing. Nat Methods 76: 461-5 (2010).
43. Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Science 3155815: 1141-3 (2007).
44. Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, Park IH, et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 274: 361-8 (2009).
45. Shock LS, Thakkar PV, Peterson EJ, Moran RG, Taylor SM. DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc Natl Acad Sci USA 1089: 3630-5 (2011).
46. Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, et al. Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res 703: 357-60 (2002).
47. Reddy PH, Beal MF. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 142: 45-53 (2008).
48. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 219: 3017-23 (2001).